Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025)
Inventiva (IVA) recorded quarterly Non-Current Deffered Revenue of $146669.5 in Q4 2025, down 99.9% quarter-over-quarter from $142.6 million in Q2 2025, and up 28.28% on a YoY basis from $114339.7 in Q4 2024.
Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends
Inventiva's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $146669.5 for Q4 2025.
- In Q4 2025, Non-Current Deffered Revenue rose 28.28% year-over-year to $146669.5; the TTM figure through Dec 2025 stood at $146669.5 (up 28.28% YoY), while the FY2025 annual figure was $146669.5, up 28.28% from the prior year.
- Non-Current Deffered Revenue was $146669.5 for Q4 2025 at Inventiva, down from $142.6 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $142.6 million in Q2 2025 to a low of $56113.6 in Q4 2022.
- Historically, Non-Current Deffered Revenue has averaged $23.8 million across 4 years, with a median of $94827.8 in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue surged 51.81% in 2024, then gained 28.28% in 2025.
- A 4-year view of Non-Current Deffered Revenue shows it stood at $56113.6 in 2022, then jumped by 34.22% to $75315.8 in 2023, then surged by 51.81% to $114339.7 in 2024, then gained by 28.28% to $146669.5 in 2025.
- The last three Non-Current Deffered Revenue figures came in at $146669.5 (Q4 2025), $142.6 million (Q2 2025), and $114339.7 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Inventiva | 8.64 Mn | -260.09 Mn | - | 146,669.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,669.48 |
| Jun 30, 2025 | 142.63 Mn |
| Dec 31, 2024 | 114,339.71 |
| Dec 31, 2023 | 75,315.79 |
| Jun 30, 2023 | 66,424.39 |
| Dec 31, 2022 | 56,113.61 |
| Dec 31, 2018 | 1.91 Mn |